Sponsors / PEPG
PEPG

PepGen Inc

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
3Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping TreatmentNCT06079736PEPGPhase 2Terminated2025-08-28Actual
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1NCT06667453PEPGPhase 2Recruiting2027-03Estimated
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)NCT07220603PEPGPhase 2Recruiting2029-01Estimated

Latest recorded trial changes